Michelle Carr

Michelle Carr

Baker & McKenzie LLP


Michelle Carr is a partner in the Corporate & Securities Practice Group of Baker McKenzie's Chicago office.

Practice Focus

Michelle's practice focuses on cross-border and domestic mergers and acquisitions in a broad range of industries, including regulated industries such as healthcare. She also has experience advising clients with respect to licensing, joint ventures and other strategic transactions.

Representative Legal Matters

  • Represented a France-based pharmaceutical company in its USD 2.4 billion acquisition of a global oncology business.

  • Represented a US-based public pharmaceutical company in its divestiture of multiple global product lines.

  • Represented a clinical-stage biotechnology company in its entry into a long-term research and development collaboration with a US-based public research pharmaceutical company.

  • Represented a Germany-based specialty chemical company in its acquisition of a US-based catalyst business.

  • Represented multiple non-US biotechnology companies in their entry into development and commercialization collaborations with US biotechnology companies.

  • Represented a US-based public food and beverage company in its acquisition of a majority interest in a growing snack food brand.

  • Represented a multinational aerospace and defense company in its divestiture of its detection systems business unit.

  • Represented a US-based biopharmaceutical company in the restructuring of multiple research collaborations.


  • Illinois~United States (2013)
  • Arizona~United States (2012)


  • The University of Chicago (J.D.) (2012)
  • University of Notre Dame (B.A.) (2008)